These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29688949)

  • 1. Increased FDG Uptake in a Giant Bone Island Mimicking Malignancy.
    Ran P; Dong A; Wang Y; Zhang Y; Wu S
    Clin Nucl Med; 2018 Jun; 43(6):e209-e211. PubMed ID: 29688949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.
    Franzius C; Bielack S; Flege S; Sciuk J; Jürgens H; Schober O
    J Nucl Med; 2002 Aug; 43(8):1012-7. PubMed ID: 12163625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
    Al-Muqbel KM; Yaghan RJ; Al-Omari MH; Rousan LA; Dagher NM; Al Bashir S
    Nucl Med Commun; 2016 Jun; 37(6):593-601. PubMed ID: 26813990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ¹⁸F-FDG PET/CT in differentiation of a benign lesion and metastasis on the ribs of cancer patients.
    Choi HS; Yoo IeR; Park HL; Choi EK; Kim SH; Lee WH
    Clin Imaging; 2014; 38(2):109-14. PubMed ID: 24361174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced osteosarcoma might mimic metastatic bone lesions: a case with bone scan and FDG PET/CT imaging.
    Koyama M; Koizumi M; Umayahara K; Takeshima N; Takahashi S
    Clin Nucl Med; 2015 May; 40(5):427-9. PubMed ID: 25608153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
    Kubo T; Furuta T; Johan MP; Ochi M
    Eur J Cancer; 2016 May; 58():104-11. PubMed ID: 26990930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-time point
    Parghane RV; Basu S
    Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare case of osteopetrosis mimicking osteosarcoma: 18F-FDG PET/CT findings in an unexpected diagnosis.
    Ferrari C; Niccoli Asabella A; Altini C; Rubini G
    Nuklearmedizin; 2016; 55(1):N1-3. PubMed ID: 26875431
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
    Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18-FDG PET in Paget's disease of bone.
    Cook GJ; Maisey MN; Fogelman I
    J Nucl Med; 1997 Sep; 38(9):1495-7. PubMed ID: 9293817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    J Comput Assist Tomogr; 2007; 31(5):812-9. PubMed ID: 17895798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Multiple Extraskeletal Osteosarcomas.
    Sun ZK; Shen CT; Qiu ZL; Luo QY
    Clin Nucl Med; 2018 Nov; 43(11):e412-e413. PubMed ID: 30106862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis mimicking metastases by malignancy in FDG PET/CT.
    Liu B; Dong L; Wang X; Han T; Lin Q; Liu M
    QJM; 2017 Mar; 110(3):173-174. PubMed ID: 28077735
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
    Nakamoto Y; Osman M; Wahl RL
    Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT in a rare malignant extraskeletal osteosarcoma.
    Cao Q; Lu M; Huebner T; Dilsizian V; Chen W
    Clin Nucl Med; 2013 Sep; 38(9):e367-9. PubMed ID: 23856822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
    Kim MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2008 Feb; 44(2):148-52. PubMed ID: 17350879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
    Hoshi M; Takada J; Oebisu N; Hata K; Ieguchi M; Nakamura H
    Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypermetabolic giant: 18F-FDG avid giant cell tumor identified on PET-CT.
    O'Connor W; Quintana M; Smith S; Willis M; Renner J
    J Radiol Case Rep; 2014 Jun; 8(6):27-38. PubMed ID: 25426232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.
    Hurley C; McCarville MB; Shulkin BL; Mao S; Wu J; Navid F; Daw NC; Pappo AS; Bishop MW
    Pediatr Blood Cancer; 2016 Aug; 63(8):1381-6. PubMed ID: 27082077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
    Hamada K; Tomita Y; Inoue A; Fujimoto T; Hashimoto N; Myoui A; Yoshikawa H; Hatazawa J
    Ann Nucl Med; 2009 Jan; 23(1):89-95. PubMed ID: 19205843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.